Breaking News, Financial News

Financial Report: Kendle 3Q10

Early Stage revenues were $6.3 million (-4%). Late Stage revenues were $76.2 million (-17%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle 3Q10 3Q Revenues: $112.6 million (-16%) 3Q Earnings: $1.5 million (earnings were $8.8 million in 3Q09) YTD Revenues: $340.4 million (-19%) YTD Earnings: $4.6 million (earnings were $12.9 million YTD10) Comments: Early Stage revenues were $6.3 million (-4%). Late Stage revenues were $76.2 million (-17%). Contract cancellations and related adjustments in the quarter totaled $10.4 million. Backlog at Sept. 30th totaled $807.4 million (+4%). Service revenues in the quarter tota...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters